Concepedia

Sachin Sethi

SS

Statistics

Publications

3

Citations

67

H-Index

3

Active since

2010

Affiliations

Aurobindo Pharma (United States)(Current)

Sachin Sethi is an author at Aurobindo Pharma (United States) specializing in medicine, pharmacology, and medicinal chemistry.

ORCID

Publications per year

2010–2017

3

Publications

3

Nature of action of sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals

JosephA Davis, Shuchita Singh, Sachin Sethi et al. · Indian Journal of Pharmacology · 2010 · 35 citations · Full text

, , +17

Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndrome

Jitendra A. Sattigeri, Sachin Sethi, Joseph A. Davis et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 18 citations · Full text

, , +9

RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes

Shuchita Singh, Sachin Sethi, Vivek Khanna et al. · European Journal of Pharmacology · 2010 · 14 citations

, , +12

1–3 of 3